All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
Patients with MPN are at increased risk of thrombosis and require treatment to prevent recurrent thromboembolic events. Anticoagulants suppress the synthesis or function of various clotting factors, thereby reducing thrombotic events. New types of anticoagulants are being investigated for the treatment of MPN.
Save to your areas of interest